These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13199603)

  • 1. [Anti-tyrosinase activity of the serum: preliminary note on the possibility of serodiagnosis of malignant melanoma].
    GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(2):145-7. PubMed ID: 13199603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of tyrosinase in normal and diseased pigment cells of the skin by means of radioactive tyrosine; original slide method; its applications in diagnosis of malignant melanoma].
    GRUPPER C; FITZPATRICK TB; LERNER AB; KUKITA A
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(1):35-7. PubMed ID: 13182442
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Applications of the histochemical method for the detection of tyrosinase in the diagnosis of melanocarcinomas].
    CASTERMANS-ELIAS S
    Arch Belg Dermatol Syphiligr; 1959 Apr; 15(1):13-21. PubMed ID: 13661936
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma and fibrothecoma--an ovarian mixed tumor.
    Nickel J; Briese V; Briese J; Rehda E
    Anticancer Res; 2005; 25(3A):1603-6. PubMed ID: 16033067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients.
    Gabri MR; Vazquez V; Girón S; Castro MA; Cinat G; Gomez RE; Santoro FM; Gomez DE; Alonso DF
    Int J Mol Med; 2008 May; 21(5):555-9. PubMed ID: 18425346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparations.
    Angeletti C; Khomitch V; Halaban R; Rimm DL
    Diagn Cytopathol; 2004 Jul; 31(1):33-7. PubMed ID: 15236262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Kusić Z
    Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase activity in the cellular fractions of Harding-Passey melanoma.
    ROBERTSON CH; BERGENDAHL JC; ADAMS EC
    Tex Rep Biol Med; 1957; 15(1):78-83. PubMed ID: 13409282
    [No Abstract]   [Full Text] [Related]  

  • 13. Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
    Patel D; Balderes P; Lahiji A; Melchior M; Ng S; Bassi R; Wu Y; Griffith H; Jimenez X; Ludwig DL; Hicklin DJ; Kang X
    Hum Antibodies; 2007; 16(3-4):127-36. PubMed ID: 18334748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignant melanoma of the vermilion of the lip.
    Van Wingerden JJ; De Visscher JG; Raubenheimer EJ
    S Afr J Surg; 2007 May; 45(2):66-8, 70-2. PubMed ID: 17674566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status.
    Savoia P; Osella-Abate S; Comessatti A; Nardò T; Marchiò C; Pacchioni D; Quaglino P; Bernengo MG
    J Clin Pathol; 2008 Feb; 61(2):179-83. PubMed ID: 17675535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated MIA levels in the serum of pregnant women and of children.
    Bosserhoff AK; Küster H; Hein R
    Clin Exp Dermatol; 2004 Nov; 29(6):628-9. PubMed ID: 15550140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes.
    Starz H; Haas CJ; Schulz GM; Balda BR
    Mod Pathol; 2003 Sep; 16(9):920-9. PubMed ID: 13679456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
    Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.